The Texas Alzheimer’s Research and Care Consortium (TARCC) is a collaboration between ten of the state’s leading medical research institutions, working to improve early diagnosis, treatment, and prevention of Alzheimer’s disease. University of Texas Medical Branch at Galveston and University of Texas Health Science Center at Houston added by Council action Feb. 2018.
1 in 9 people age 65+ has Alzheimer's disease.
About 490,000 Texans are projected to have Alzheimer's by 2025.
Every 66 seconds, someone in the United States develops Alzheimer’s.
TARCC Research Updates
TARCC investigators have been involved in a number of new, important research studies. Recently published research is wide ranging, spanning the gamut from clinical trials to new cognitive diagnostics; blood-based biomarkers in Mexican-Americans; identification of additional risk genes; and validation of biomarker algorithms in AD patients and AD animal models.
View all TARCC researcher publications here.
Request for Applications
Applications Due March 20, 2020 by 5pm CST
(Anticipated funding to begin in the summer of 2020)
The Texas Alzheimer’s Research and Care Consortium (TARCC) is pleased to announce its FY2020 Request for Applications (RFA) as part of a research program to support an innovative, translational-based research structure at member institutions across the state of Texas, and to ensure that a diverse pool of well-trained clinician-scientists are available in Texas to aid in the fight against Alzheimer’s disease and related disorders.